DEA Schedule II–IV handling for anesthetic carpules (lidocaine, articaine) — what changes in checkout?

Most dental anesthetics are not federally scheduled. Lidocaine, articaine, mepivacaine, bupivacaine, prilocaine — all Rx, none scheduled federally. But a few items dental distributors carry are scheduled:

• Halcion (triazolam) — Schedule IV, used for sedation dentistry
• Versed (midazolam) — Schedule IV, sedation
• Codeine-containing analgesics — Schedule II or III depending on formulation
• Vicodin / Norco (hydrocodone) — Schedule II
• Nitrous oxide — not federally scheduled but state-restricted in CA, NJ, several others

Checkout changes for scheduled items:

• DEA registration validation per buyer-account at signup — the clinic or dentist must have an active DEA registration matching their license type. Validate against the DEA registrant database (Inflexxion / DEA NTIS feed) at signup and annually.
• CSOS (Controlled Substance Ordering System) for Schedule II — electronic ordering between DEA-registrants using PKI digital signatures. CSOS replaces the paper DEA Form 222. Required for Schedule II.
• State-by-state restrictions enforced at checkout (e.g. pseudoephedrine quantity caps, MA-only Schedule III tracking).
• Biennial inventory + Suspicious Order Monitoring (SOM) reports — auto-flag orders deviating from the buyer’s historical pattern (3× volume, new product class, etc.). Required by DEA Final Rule 2020.
• Closed-system records — every Schedule II transaction logged with DEA registration of buyer + seller, immutable.

Implementation: ~6–10 weeks of dev time on Magento. Most dental supply distributors don’t carry Schedule II controls (those go through speciality pharma distributors); Schedule IV is the practical scope.